Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Nasdaq - Delayed Quote USD

ProFunds Biotechnology UltraSector Fund (BIPSX)

21.25
-0.42
(-1.94%)
At close: March 28 at 8:00:07 PM EDT

Top 5 Holdings (11.10% of Total Assets)

SymbolCompany% Assets
GILD
Gilead Sciences, Inc. 2.33%
AMGN
Amgen Inc. 2.22%
SRPT
Sarepta Therapeutics, Inc. 2.20%
ABBV
AbbVie Inc. 2.19%
EXAS
Exact Sciences Corporation 2.17%

Sector Weightings

SectorBIPSX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 19.67%
Stocks 78.77%
Bonds 0.00%
Others -0.65%
Preferred 0.00%
Convertible 2.21%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average BIPSX Category Average
Price/Earnings 0 0
Price/Book 0.23 3.89
Price/Sales 0.13 2.3
Price/Cashflow 0 0
Median Market Cap 8,143.27 140,046.23
3 Year Earnings Growth 0 0

Bond Holdings

Average BIPSX Category Average
Maturity -- --
Duration 7 --
Credit Quality -- --

Performance & Risk

YTD Return -9.03%
5y Average Return 7.58%
Rank in Category (ytd) --
% Rank in Category (ytd) --
Beta (5Y Monthly) 1.44
Morningstar Risk Rating

Fund Overview

Category Trading--Leveraged Equity
Fund Family ProFunds
Net Assets 78.22M
YTD Return -3.36%
Yield 0.00%
Morningstar Rating
Inception Date Jun 19, 2000

Fund Summary

The fund invests in financial instruments that the fund advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index represents the biotechnology segment of the S&P Total Market Index, which comprises the following sub-industry: biotechnology. The fund is non-diversified.

Related Tickers